During SARS-CoV-2 infection, ADAM17 contributes to COVID-19 pathogenesis by promoting the shedding of angiotensin-converting enzyme 2 (ACE2), thereby disrupting its protective signaling axis. Here, ACE2 is linked to COVID-19.